Micropipette manipulation technique for the monitoring of pH-dependent membrane lysis as induced by the fusion peptide of influenza virus  by Soltesz, S.A. & Hammer, D.A.
Biophysical Journal Volume 68 January 1995 315-325
Micropipette Manipulation Technique for the Monitoring of pH-Dependent
Membrane Lysis as Induced by the Fusion Peptide of Influenza Virus
Sharon A. Soltesz and Daniel A. Hammer
School of Chemical Engineering, Cornell University, Ithaca, New York 14853 USA
ABSTRACT We have assembled a micropipette aspiration assay to measure membrane destabilization events in which large
(20-30 pm diameter) unilamellar vesicles are manipulated and exposed to membrane destabilizing agents. Single events can
be seen with a light microscope and are recorded using both a video camera and a photomultiplier tube. We have performed
experiments with a wild-type fusion peptide from influenza virus (X31) and found that it induces pH-dependent, stochastic lysis
of large unilamellar vesicles. The rate and extent of lysis are both maximum at pH 5; the maximum rate of lysis is 0.018 s-I
at pH 5. An analysis of our data indicates that the lysis is not correlated either to the size of the vesicles or to the tension created
in the vesicle membranes by aspiration.
INTRODUCTION
Membrane fusion is an important and widespread phenom-
enon in cell biology. The entry of viruses into cells, endo-
cytosis, exocytosis, cell division, fertilization, polykaryon
formation in bone and muscle, and communication between
intracellular compartments all involve the fusion of two
membranes (Blumenthal, 1987). In addition, membrane fu-
sion has potential for use in directed drug delivery, where
pharmaceutical agents are targeted to a specific organ in the
body (Szoka, 1991; Mayhew, 1988); it is possible that the
pharmaceutical agent could be more effectively delivered to
the target cells by having them fuse specifically with the
liposomes. Many books have been published about mem-
brane fusion, including those edited by Duzgunes (1993),
Bentz (1993), Wilschut and Hoekstra (1991), Ohki et al.
(1988), Duzgunes and Bronner (1988), and Sowers (1987).
The entry of enveloped viruses into cells is perhaps the
most widely studied membrane fusion event (for recent re-
views, see Bentz, 1993; Zimmerberg et al., 1993; White,
1990, 1992; Hoekstra, 1990; Stegmann et al., 1989). Almost
all enveloped viruses have a protein on their surface that
mediates the fusion of the viral membrane with either the
plasma membrane or endosome membrane of the target cell.
Many fusion proteins have in common a hydrophobic se-
quence of amino acids that is called the "fusion peptide." In
some cases, as with influenza virus, the fusion peptide is at
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the N-terminus of the fusion protein; in other cases, as with
Semliki Forest virus, the fusion peptide is in the middle of
the sequence.
The mechanism by which influenza virus infects a cell has
been particularly widely studied. The virus binds to sialic
acid on the target cell surface, and the entire virus is endo-
cytosed into the cell. This endocytosed vesicle combines
with an endosome, and the pH of the compartment is reduced.
At the lower pH, influenza virus hemagglutinin undergoes a
conformational change, exposing the fusion peptide. There
are many proposed models for the mechanism by which
influenza hemagglutinin causes fusion (Kemble et al.,
1994;Carr and Kim, 1993; Tse et al., 1993; Zimmerberg
et al., 1993; Guy et al., 1992; Bentz et al., 1990; Stegmann
et al., 1990), but the details have been difficult to elucidate
experimentally.
It is known, for example, that the fusion peptide is nec-
essary for fusion. Mutants of influenza hemagglutinin that
have altered or missing fusion peptides have altered (Daniels
et al., 1985) or no (Gethig et al., 1986; Schoch and
Blumenthal, 1993) fusion activity. What is less clear is ex-
actly how much of the fusion protein is needed for fusion
activity, and whether the fusion peptide alone is sufficient to
cause membrane fusion. There is mounting evidence that the
entire hemagglutinin molecule may be necessary to stabilize
the membrane fusion site (White, 1992). In addition, there is
evidence that the fusion peptide also serves to stabilize the
structure of the hemagglutinin protein at neutral pH (Carr and
Kim, 1993; Yewdell et al., 1993).
The fusion peptide from influenza virus hemagglutinin,
which is found at the N-terminus of the protein, has also been
widely studied. Wharton et al. (1988) found that an X31
wild-type peptide 20 amino acids long induced fusion of
POPC small unilamellar vesicles (SUV) in a pH-dependent
manner; fusion was much more extensive at pH 5 than pH
7. Duzgunes and Gambale (1988), however, found that a 17
amino acid analog of X31 induced lysis, but not fusion, of
PS/PC large unilamellar vesicles made by reverse phase
evaporation. Rafalski et al. (1991) also found that a 20 amino
acid analog of X31 induced extensive contents leakage of
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POPC large unilamellar vesicles in a pH-dependent manner.
In a recent report, Duzgunes and Shavnin (1992) again re-
ported destabilization, but no fusion, of large PC liposomes
by a 17 amino acid analog of the fusion peptide from the X31
strain of influenza virus.
Previous fusion studies using fluorescence have been
largely done in one of two ways. In the first method, vesicles
or cells labeled with fluorescent probes are placed in a well
mixed fluorometer cuvette at the desired experimental con-
ditions. The fluorescent probes are often donor-acceptor
pairs that can be used in a variety of configurations. Lipid
soluble dyes are used to monitor membrane mixing; aqueous
dyes are used to monitor contents mixing. By monitoring the
fluorescence as a function of time, the rate of fusion can be
inferred from the extent of fusion by invoking a mass-action
model (Duzgunes and Bentz, 1988). In this model, two
vesicles are first assumed to adhere reversibly, and then they
irreversibly fuse in a second step. Only bulk properties from
the entire population of vesicles can be inferred from these
experiments and such a model, and much information about
individual fusion events is lost. This is because individual
events are overcome by the heterogeneous behavior of the
population. Also, fusion and lysis are often seen in the same
experiment; it is not always easy to observe which comes first
in bulk experiments.
The other method that has been used widely is the fusion
of vesicles with a planar bilayer. In this method, a planar
bilayer is constructed in a hole in a Teflon substrate (Mueller
et al., 1962; White, 1978). The bilayer is formed by spreading
a solution of lipid in some organic solvent, usually decane
or squalene, across the hole. Alternately, the bilayer can
be formed by the apposition of monolayers (Montal and
Mueller, 1972; Tancrede et al., 1983). With time, the solvent
is excluded from the bilayer and the membrane thins. After
the bilayer is formed, vesicles containing membrane mixing
or, more commonly, contents mixing dyes are either injected
toward the bilayer from below or are allowed to settle onto
the membrane from above by gravity. The fusion is moni-
tored with a microscope focused at the bilayer surface. Fu-
sion events thus appear as a bright flash (Melikyan et al.,
1993; Perin and MacDonald, 1989; Woodbury and Hall,
1988; Niles and Cohen, 1987). Although this method has the
advantage of being able to distinguish single fusion events,
it very difficult to construct a planar membrane without some
solvent remaining in the bilayer. Because such solvents are
known to stabilize inverted membrane phases (Siegel et al.,
1989), it is possible that they would also have an effect on
membrane fusion, because many proposed fusion interme-
diates contain structures similar to those found in inverted
phases.
Another assay in which membrane fusion has been studied
is that of Liu et al. (1988), in which large fluorescent vesicles
are imaged as pixels on a video screen. The relative bright-
ness of the pixels is related to their size and the amount of
dye loaded within them; coupled with measurements of the
size distribution of vesicles, membrane fusion can be moni-
imaged, but fusion can only be inferred by a shift in the
population fluorescence profile. Direct information about in-
dividual fusion events is lost.
To overcome some of the problems associated with the
assays mentioned above, we use a micropipette aspiration
technique in which two large vesicles are brought into close
contact with micropipette manipulators. The vesicles are
large enough to be seen with a light microscope and, thus,
the progress of a single membrane interaction event can be
monitored. Micropipette aspiration has been used previously
to study adhesion of cells and vesicles (Tozeren et al., 1989;
Evans and Metcalfe, 1984a, b; Evans, 1980), the mechanical
properties of membranes (Needham and Evans, 1988; Evans
and Needham, 1987), and electrofusion of adherent vesicles
(Needham, 1993). In addition, micropipette aspiration has
been used to study exocytosis in single cells by monitoring
the membrane capacitance of whole cells, as reviewed by
Lindau (1991). In this study, we use micropipette aspiration
to measure the pH-dependent lysis caused by the fusion pep-
tide from the X31 strain of influenza virus.
MATERIALS AND METHODS
Materials
Egg PC and NBD-PE were purchased from Avanti Polar Lipids, Inc.
(Pelham, AL). ANTS was purchased from Molecular Probes, Inc. (Eugene,
OR). All other chemicals were reagent grade or better.
Experimental buffer
All experiments were conducted in a mixed buffer containing 0.1 M glucose,
1 mM HEPES, 1 mM MES, and 1 mM sodium citrate. This combination
of buffers was chosen because it would buffer the solution over the entire
desired experimental pH range of 4-7. Also, it was slightly more hyper-
osmolar (106 vs. 100 mOsm/kg) than the solutions the vesicles were stored
in, allowing them to become slightly flaccid for micromanipulation.
Peptide synthesis
Peptide X31, the fusion peptide from the X31F/68 strain of influenza virus,
was synthesized for us by Star Biochemicals, Inc. (Torrance, CA). The
molecular weight of the peptide was confirmed by mass spectrometry to be
2036. The molecular weight determination was performed for us by Multiple
Peptide Systems, Inc. (San Diego, CA). The sequence of the peptide is
NH2-GLFGAIAGFIENGWEGMIDG-COOH.
Peptide concentration was verified for each trial using the Pierce Coo-
massie Plus Protein Assay Reagent (Pierce Chemical Company, Rockford,
IL). After each trial, the contents of the experimental chamber were removed
with a pipettor and placed in a microfuge tube. These tubes were frozen until
the Coomassie assay was performed within several days; in this way, we
were able to confirm that we had the desired concentration of peptide in the
chamber at the end of every trial. Thus, we were able to rule out potential
artifacts such as peptide absorption to tubing or chamber walls.
Vesicle synthesis
Vesicles are synthesized using the dehydration/rehydration technique origi-
nally developed by Reeves and Dowben (1969) and modified by Needham
and Evans (1988). Briefly, a solution of lipid in chloroform is spread on atored with this system. In this assay, individual vesicles are
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dry ovemight under vacuum in nitrogen at 40°C. The lipid is then prehy-
drated in water-saturated nitrogen for several hours. After prehydration, the
aqueous solution of interest at 40°C is carefully pipetted over the substrate.
Vesicles appear as a "cloud" overnight and are carefully harvested with a
pipettor.
Generally, vesicles are made in a solution containing 0.1 M sucrose plus
2 mM ANTS. Vesicles are separated from unencapsulated fluorophore as
follows. First, the vesicle suspension is diluted with an equal volume of 0.1
M glucose. Because glucose solutions are less dense than sucrose solutions,
the vesicles can be pelleted by centrifuging at 210 X g for 10 min. Vesicles
can then be resuspended in 0.1 M sucrose.
Vesicles were determined to be stable for up to 5 days after harvesting.
Vesicles used in experiments were used within 48 h after they were har-
vested and had diameters of 15-30 ,lm, the most typical diameter being 22
,um. Vesicle diameters were determined using an eyepiece reticle at 600X
and phase contrast optics.
Pipettes
Pipettes are manufactured using 1 mm inner diameter thick-walled capillary
tubes made by Narishige (Greenvale, NY; type GD-1). First, pipettes with
needle tips are made using a PB-7 vertical gravity puller (Narishige, Gre-
envale, NY). The needle tip is broken off using a microforge (Technical
Products International, Inc., St. Louis, MO), and the resulting larger tip is
fire-polished using the microforge. Pipettes are sized using an eyepiece
reticle at 600X and bright-field optics. Pipettes used in experiments have
inner diameters of 6-10 ,um, the most typical diameter being 8 ,um.
Pipettes are filled with the same glucose buffer in which the experiment
is performed. The tips are filled by capillary action by immersing them in
glucose buffer; the thinned portion of the pipette fills in less than an hour.
The remainder of the pipette is backfilled using a syringe with a 31 gauge
needle.
Chamber
The experimental chamber is essentially a channel that has 0.125 inch high
walls. It is 0.25 inch wide and 1 inch long at the bottom. The side walls are
sloped, allowing for the entry of micropipettes at an angle. The bottom of
the chamber is a glass microscope slide that allows for viewing with an
inverted microscope. One side of the chamber has a 0.03 inch hole bored
into it through which solutions can be injected.
FIGURE 1 Schematic of experimental equip-
ment.
Fluorescence assays
For lysis experiments, a single population of vesicles is synthesized, with
2mol% NBD-PE in the membrane and 2mMANTS in the aqueous contents.
Because the vesicles are held in the micropipettes with a small suction
pressure (0.5 cm H20 5 x 10'- atm), lysis results in the vesicle being
sucked into the pipette and out of the field of view of the microscope ob-
jective, because the membrane is no longer continuous. When using the
fluorescence assays, then, a lysis event is seen as a decrease in fluorescence
of both NBD-PE and ANTS. Using video microscopy only, the vesicle is
seen to deflate abruptly and is sucked into the pipette. This type of rapid
disruption is consistent with previous micropipette experiments such as
those by Zhelev and Needham (1993) when aspiration pressures such as ours
(0.5 cm H20) are used.
These fluorophores (NBD and ANTS) were chosen because they have
different excitation wavelengths but similar emission wavelengths. NBD
excites at 460 nm and emits at 534 nm; ANTS excites at 370 nm and emits
at 515 nm. In this way, we can alternately excite the two fluorophores while
monitoring their emission with one set of equipment. We use 355 and 460
nm bandpass filters to excite ANTS and NBD, respectively. A dichroic
mirror with extended UV region allows the excitation wavelengths to be
reflected up to the sample while allowing emitted light to pass through; the
emitted light is passed through a 535 nm bandpass filter. All of these filters
were purchased from Omega Optical, Inc. (Brattleboro, VT).
Experimental equipment
Fig. 1 shows an overall schematic of our experiment. The Nikon Diaphot
TMD inverted microscope is equipped for epifluorescence. The fluorescent
light source is a Xenon lamp equipped with a chopper wheel that is used
to excite alternately the two fluorophores. The emitted light can be sent to
a photomultiplier tube and/or an intensified video camera. The chopper
wheel and photomultiplier tube are coordinated with an NEC PowerMate
286 Plus computer (NEC Information Systems, Inc., Boxborough, MA). The
computer, xenon lamp, chopper wheel, and photomultiplier tube collectively
are the Photoscan-2 System from Nikon, Inc. (Melville, NY). The model
CCD-200E camera and model KS-1381 image intensifier are from Video
Scope International, Ltd. (Washington, D.C.). Video images are recorded
using a JVC S-VHS VCR with time base corrector and time code reader/
generator boards installed (JVC, Elmwood Park, NJ). In addition, we have
the capability to do image analysis with a Sun workstation equipped with
Inovisions image analysis software (Inovisions Corporation, Durham, NC).
Lamp and Chopper Wheel
P Excitation Filters
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The microscope, xenon lamp, and manometers sit on a Research Series Plus
isolation table from Newport Corporation (Irvine, CA).
With the photomultiplier tube and video camera combination, we can
obtain several types of data. The photomultiplier tube gives information on
a very short time scale (up to 500 points per second) but does not provide
any spatial information. This is useful for careful kinetic measurements. The
intensified video camera, although providing information on a much longer
time scale (30 frames per second), does give spatial information. This could
be used, for example, to follow the diffusion of fluorophores from one
vesicle to the other.
Fig. 2 shows a schematic of the microscope stage and the equipment used
to control the position of and the pressure within the micropipettes. Trans-
lation stages from Newport Corporation (Irvine, CA) allow for control of
motion of the micropipettes on the order of centimeters along all three axes.
Precise control of motion on the order of microns is possible using stage-
mounted micromanipulators from Technical Products, Inc. (St. Louis, MO);
the operator performs the fine motion using pneumatic joystick controllers
connected to the manipulators by tubing.
The pressure within the pipettes is controlled using micrometer manom-
eters machined for us by Research Instruments, Inc. (Durham, NC); the
pipettes are connected to the manometers through the wet chuck as shown
in Fig. 2. Essentially, the pressure is controlled by adjusting the relative
heights of two water-filled reservoirs on the manometer. We can control
pressure down to increments of 5 ,um of water (-5 X 10- atm). The
pressure is monitored using sensitive differential pressure transducers (Mod-
els DP15 and DP103) manufactured by Validyne Engineering Corporation
(Northridge, CA).
Experimental protocol
100 ,u1 of vesicle solution is diluted with 600 u1l of glucose buffer and, after
vortexing, this solution is placed in the chamber. The vesicles are allowed
to settle for 10 min; the vesicles are more dense than the glucose buffer
because they contain sucrose. The pipettes are zeroed, and then one or two
vesicles are aspirated, depending upon the configuration used. The pipettes
holding the vesicles are then aligned and the size of the vesicle(s) is meas-
ured. The VCR is then started, and 100 ,ul of peptide solution is injected into
the chamber. Alternately, for fluorescence measurements, the lights are
turned off, the photomultiplier tube scan is started, and peptide is injected
into the chamber. Videotaped experiments are allowed to progress until the
vesicles lyse or until a period of 15 min has passed. Generally, photo-
multiplier traces were 2 min long.
translation stages allow for
,coarse positioning along all
three axes
1
FIGURE 2 Schematic of equipment used to control position of micropi-
pettes on microscope stage. Manometers are connected to the micropipettes
through the wet chuck.
Most of the results presented in this paper were obtained using phase
contrast optics and the video camera (unintensified) only, because it was
found that the lysis events induced by X31 often did not start for several min.
Because there is a limitation on the number of data points that can be
collected in a single trace with the Photoscan system (10,000 points), it
cannot be run for very long at a high rate of data collection. For lysis events
that occur on the order of many minutes, the video images give better time
resolution. All experiments were performed at room temperature (22-24°C).
Vesicles selected for use in experiments were the ones that appeared the
most transparent, had the thinnest membranes, and had no visible internal
structures. Determinations of lysis pressures of typical vesicles agree within
our experimental error with those of Evans and Needham (1987) for unila-
mellar vesicles made of egg PC. Our measured lysis tensions were several
dynes/cm, well above the tensions exerted by our small aspiration pressures.
RESULTS
With our assay, we can obtain more than one type of data.
Fig. 3 shows fluorescence traces for one lysis event induced
by peptide X31 at pH 5 and a concentration of 10 ,uM. Data
were collected at a rate of 20 points per second. As expected,
lysis results in a decrease in fluorescence as recorded by both
assays. Both fluorophore traces show that the vesicle lysed
at a time of 32.95 s, or -3 s after injection. (Peptide was
injected at 30 s.) The exact lysis time is determined by nar-
rowing the x axis range to the region of interest (in this case
32-34 s) and locating the point at which the fluorescence
begins to decrease.
At most of the conditions tested, and in contrast to the lysis
event shown in Fig. 3, most (but not all) of the lysis events
occurred very slowly, on a time scale of minutes. Therefore,
most of the data reported in this paper were obtained using
video microscopy. Fig. 4 shows a sequence of video frames
obtained in such an experiment. Fig. 4 A shows the two
vesicles manipulated into the vicinity of each other at the
time of injection. The right vesicle begins to lyse 3 s after
30
time, seconds
FIGURE 3 Fluorescence traces of vesicle lysis caused by peptide X31.
Data were collected at a rate of 20 points per second. Peptide X31 at 10 ,uM
and pH 5 was injected into the chamber at t = 30 s. (A) Membrane flu-
orophore (NBD-PE) trace. (B) Aqueous fluorophore (ANTS) trace. Both
traces show that lysis occurred at a time between 32 and 33 s. The bumps
at the end of the membrane fluorophore trace result from bright, multila-
mellar vesicles floating by the field of view of the microscope objective.
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FIGURE 4 Video time sequence showing lysis induced by peptide X31. Numbers at the top of each frame indicate the time code for that frame (h:
min:s:frames). Peptide X31 at 10 ,M and pH 5 was injected at time 2:09:10:00. The dashed line seen in F, G, and H is an artifact produced by our VCR.
(A) Vesicles in contact at the time of injection. (B) Right vesicle begins to lyse. (C-E) Right vesicle shrinks and disappears, characteristic of lysis. (F)
Left vesicle begins to lyse. (G-H) Left vesicle shrinks and disappears..
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injection (Fig. 4 B). In 7 frames (7/30 second), the right
vesicle shrinks and disappears, characteristic of lysis (Fig. 4
C-E). About one and one-half min after injection, the left
vesicle begins to lyse (Fig. 4 F). In 4 frames (2/15 second),
the left vesicle shrinks and disappears (Fig. 4, G and H). This
type of behavior, where the vesicles lyse separately and in-
dependently of one another, was seen repeatedly.
Both types of experiments show that once lysis begins, it
is completed very quickly, in less than a second. It thus ap-
pears that once a defect forms in the vesicle membrane, the
vesicle is drawn into the pipette. This holds true for all con-
ditions tested (data not shown). It is likely that the constant
time for completion of lysis is due to the constant small
suction pressure that is used to aspirate the vesicles.
Results of X31 lysis experiments
Fig. 5 shows the time for lysis to start as a function of pH.
All of these experiments were performed at a concentration
of 10 ,uM. Peptide X31 has maximum activity at pH of 5,
inducing lysis much more quickly at pH 5 than at any other
pH. Although one cannot easily compare the lysis mean
times at pHs 6 and 7 to the others because of the low number
of lysis events seen at those pHs, there are statistical dif-
ferences in mean lysis time as a function ofpH. For example,
between pH 4 and 5, an unpaired t-test shows that the means
are statistically different (>99% probability). One can define
a rate of lysis by taking the inverse of the mean lysis time
at each condition. As an example, the lysis rate at pH 5 is
0.018 s-1, which is the highest rate we observed for peptide
X31 at 10 ,uM. The ability to report absolute rates of lysis
is one of the advantages of our system.
As can be seen in Fig. 5, more vesicles lyse at pH 5 and
below than at higher pH; in fact, not all vesicles exposed to
peptide actually lyse. Fig. 6 shows a graph of percent lysis
as a function of pH. Percent lysis is defined as the number
'0
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FIGURE 5 Plot of lysis start time versus pH for peptide X31. Data at pH
5 were taken both with fluorescence and video microscopies; data at all other
pHs were taken using video microscopy only. Error bars are SEM; n =
number of vesicles that lysed. Vesicles that did not lyse are not accounted
for in this graph.
FIGURE 6 Plot of percent lysis versus pH for peptide X31. Data at pH
5 were taken both with fluorescence and video microscopies; data at all other
pHs were taken using video microscopy only. Percent lysis is defined as the
number of vesicles that lysed divided by the total number of vesicles tested
at a given condition. Here, n represents the total number of vesicles (vesicles
that lysed plus vesicles that did not lyse).
of lysed vesicles divided by the total number of vesicles.
These data also show maximum activity at pH 5; however,
there is a plateau at lower pHs. That is, even though the lysis
occurs very slowly, as shown in Fig. 5, a majority of the
vesicles eventually lyse at pHs less than or equal to 5. The
differences as a function of pH are perhaps more significant
here, because the numbers of events is approximately equal.
So, if one considers activity measured by percent lysis, it is
clear that there is an effect of pH on lysis activity. As dis-
cussed below, it is the percent lysis data that can most directly
be compared with fluorometer experiments.
Possible artifacts
It is prudent to consider if our results are an artifact of our
system. The first concern is whether the size of the vesicles
being used has any effect on the results obtained. For ex-
ample, one might wonder whether larger vesicles are inher-
ently more unstable than small ones, because one obtains
only a few large vesicles (20-30 ,um) compared with a large
number of smaller vesicles using our synthesis method. If
this were true, the expected observation would be that
vesicles that do not lyse are smaller overall than vesicles that
do lyse. Table 1 shows a summary of the mean vesicle di-
ameters for both conditions; statistically, the means are not
different.
Another test of this hypothesis is whether larger vesicles
lyse more quickly than smaller ones. Fig. 7 shows plots of
lysis time versus vesicle diameter at four different pH values.
TABLE 1 Comparison of vesicle diameters
n* mean (gm) SD (itm)
No lysis 42 22.1 4.1
Lysis 57 22.4 5.1
*n, number of vesicles.
c,,
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FIGURE 7 Plots of lysis start time versus vesicle diameter at four different pH values. (A) pH 4. (B) pH 4.5. (C) pH 5. (D) pH 5.5.
There is no obvious relationship between lysis time and
vesicle diameter. Thus, it does not appear that the size of the
vesicles is the cause of the behavior seen.
Another concern is that, because the vesicles are held in
the micropipettes with a small suction pressure, the mem-
branes are under tension that may influence lysis. In these
experiments, it was our desire to exert sufficiently small pres-
sures, giving rise to sufficiently small tensions, such that the
effect of tension on lysis was negligible. However, because
of differences in vesicle and pipette diameters, this tension
varies from trial to trial and might have inadvertently been
the driving force behind the behavior we see. For example,
when small a defect forms in a membrane, tension might
accelerate the lysis of the vesicle; vesicles that lyse more
quickly might be those with higher membrane tensions.
Kwok and Evans (1981) have shown that the mean tension
in the membrane of a vesicle held in a micropipette can be
approximated as follows:
PRP
T 2(1 - RI/RO) (1)
where t = mean tension, P = suction pressure in pipette,
Rp = inner radius of pipette, and Ro = radius of vesicle. The
pressure within the pipette is always 0.5 cm H20 (-5 X 10-4
atm); the pipette and vesicle radii vary from trial to trial.
As with vesicle diameter, the effect of membrane tension
on lysis time can be examined in two ways. First, one must
consider whether vesicles that lyse are under more tension
than vesicles that do not lyse. Table 2 gives the means and
SDs of membrane tension for both vesicles that lysed and
vesicles that did not lyse. The two means are not statistically
TABLE 2 Comparison of membrane mean tension
n* T (dyn/cm) SD (dyn/cm)
No lysis 42 0.17 0.05
Lysis 56 0.19 0.09
*n = number of vesicles.
different, and so it appears that vesicles that lyse are not
under greater tension than those that do not lyse, at least
within our experimental error.
Second, do greater tensions lead to faster lysis? Fig. 8
shows plots of lysis time as a function of mean membrane
tension for four different pH values. The large error in the
estimates of membrane tension result from inaccuracies in
our measurements of pipette diameter, the parameter in
Eq.1 that we know with the least accuracy. Within the meas-
urement error, however, there is no effect of membrane ten-
sion on lysis time at these conditions. We conclude, then, that
within our experimental error, membrane tension is not the
source of the lysis behavior seen. In addition, Figs. 7 and 8
demonstrate that vesicle failure was quite variable under
identical conditions.
DISCUSSION
Because most fusion experiments are performed in fluoro-
meter cuvettes in which bulk fluorescence is measured as a
function of time, care must be taken in distinguishing be-
tween true fusion and other processes, such as lysis. This is
particularly true in cases where membrane mixing, aqueous
contents mixing, and contents leakage are not all measured
(Burgess et al., 1991). When a large amount of contents leak-
age is seen along with membrane fusion, it can be unclear
whether the fusion and leakage occurred simultaneously, or
if the leakage occurred after membrane fusion. Another pos-
sibility, which is hard to measure using bulk fluorometer
experiments, is that some fraction of the vesicles actually
fuse while another fraction of the vesicles lyse. One of the
true advantages of a system such as ours, in which we can
observe single membrane interaction events, is that we
should be able to determine unambiguously whether fusion
or some other process is occurring for each vesicle pair
tested. In addition, because we should be able to separate
fusion from lysis, we can determine rates of lysis (and fusion)
directly from our data, without resorting to a mass-action
model.
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FIGURE 8 Plots of lysis start time versus mean membrane tension at four different pH values. (A) pH 4. (B) pH 4.5. (C) pH 5. (D) pH 5.5. Horizontal
error bars are 50% of value, giving an estimate of the error in the measurements.
The major drawback to the micropipette method is the
large amount of time that is required to obtain statistically
significant amounts of data; in most cases, only one set of
experimental conditions can be tested on a given day. This
assay, therefore, is not suited to screening large numbers of
experimental conditions. In general, we feel that a combi-
nation of assays would be most useful: fluorometer experi-
ments could be used to screen large numbers of experimental
conditions, and then specific rate and extent information
could be obtained with the micropipette assay.
At each of the pHs reported in this paper, at least one
experiment (consisting of many trials) was performed in a
two-vesicle configuration. In all cases, the vesicles were seen
to lyse separately and independently ofone another; the times
between lysis of two neighboring vesicles may be very dif-
ferent. This behavior does not appear to be the result of a
transient fusion event that results in the eventual lysis of the
two vesicles; in such a case, the vesicles would likely be seen
to lyse at the same or close to the same time.
Although we cannot rule out the possibility that peptide
X31 causes fusion at some experimental conditions, using
our system and our buffer, we did not see fusion. Rather, we
found that X31 induces membrane lysis in a pH-dependent
manner. This agrees with the results of Duzgunes and
Shavnin (1992), Duzgunes and Gambale (1988), and
Rafalski et al. (1991), who also found that X31 induced ex-
tensive leakage of vesicle contents. Although Wharton et al.
(1988) report membrane fusion induced by X31, these ex-
periments were performed with SUV made by sonication;
such vesicles are known to have highly strained bilayers be-
cause of their extremely small radii (Gruner, 1987). Thus,
they are much more prone to fusion than vesicles with larger
radii. It is interesting to note, however, that Wharton et al.
report that about 90% of the contents of their SUVs leak
during fusion. In addition, Wharton et al. (1988) report that
peptide X31 is active in low electrolyte media, which further
supports our results.
Both Figs. 7 and 8 show the scatter of lysis times at a given
pH. That is, at constant conditions, there is a range of lysis
times seen. It does not appear that this scatter is caused by
either vesicle diameter or membrane tension, however. This
large scatter in data from single events has also been ob-
served by Kaplan et al. (1991), who observed broad hetero-
geneity in both the lag times and completion times for
membrane mixing between cells expressing influenza hem-
agglutinin on their surfaces.
Qualitatively, our results agree very well with the studies
mentioned above. It is important to consider how one defines
lysis activity. For example, the lysis rates are very slow at
pHs 4 and 4.5, but the percent lysis in both cases is very high.
We see a maximum in lysis activity measured by lysis rate
at pH 5; the lysis rate decreases at other pHs. There is also
a maximum in percent lysis at pH 5 or below. This maximum
at pH 5 is expected, because the charged residues on the
peptide have pKas of4-5. Also, the extent of lysis data, which
peaks at pH 5 but appears to plateau at lower pH, agrees
qualitatively with the plot of fusion efficiency versus pH of
Wharton et al. (1988, Fig. 2). Data at other concentrations
have been taken, and will be published separately in a more
thorough comparison of the activity of X31 and other pep-
tides (S. A. Soltesz and D. A. Hammer, unpublished data).
One of the other advantages of our assay is that we can
present actual rates of lysis (or fusion) because we derive
rates directly from individual events. We have expressed rate
as 1/time and report here that lysis occurs most rapidly at pH
5, with a rate of 0.018 s-5. Although absolute rates cannot
be derived from fluorometer experiments without invoking
a model like that of Duzgunes and Bentz (1988), it is com-
monly seen that under similar conditions, the fusion or leak-
age process takes several min to occur (Duzgiines and
Shavnin, 1992; Rafalski et al., 1991; Wharton et al., 1988).
Thus, it seems that our numbers are consistent with previous
fluorometer results.
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Because micropipette aspiration has not been widely used
to study membrane lysis, we have explored the possibilities
of artifacts in our system. First, we explored whether the size
of the vesicles themselves was responsible for the lysis be-
havior seen. One might expect that larger vesicles are in-
herently more unstable than smaller ones; one line of evi-
dence supporting this is that there are fewer numbers of large
vesicles relative to small ones after synthesis.
However, an examination of the data showed no difference
in vesicle diameter between vesicles that lysed and vesicles
that did no lyse (Table 1). Further, by plotting lysis time
versus vesicle diameter at a given pH, one sees no detectable
relationship between lysis time and vesicle diameter (Fig. 7).
We have concluded, then, that the difference in vesicle di-
ameters between trials is not the cause of the observed lysis.
Second, we have examined the effect of the membrane
tension created by vesicle aspiration on lysis time. We have
estimated that our measurements of mean membrane tension
are correct within about a factor of two, and the average
tensions were <0.2 dyn/cm. This is an order of magnitude
below the tensions required to cause membrane lysis (Evans
and Needham, 1987). The parameters in Eq. 1 that are meas-
ured experimentally are the aspiration pressure, the vesicle
radius, and the pipette inner radius. The aspiration pressure
is constant from trial to trial at 0.5 cm H20; the actual value
varies only by a few percent. Larger errors are introduced in
the measurement of vesicle and pipette radii. This is because
of the measurement method, using an eyepiece reticle at
600X magnification, which introduces errors of 1-2 ,um in
diameter. Although this is not an excessive error on the scale
of a 30 ,um vesicle, the percent error introduced for an 8 ,um
inner diameter pipette can be as large as 25%. Thus, the
measurement of pipette diameter is the largest source of er-
ror. We have plans in the near future to use a more sophis-
ticated method to measure pipette diameter and improve our
measurements of membrane tension accordingly.
Within our error, as shown in Table 2, vesicles that lyse
do not have significantly higher membrane tensions than
those that do not lyse. Further, as shown in Fig. 8, there is
no detectable relationship between lysis time and membrane
tension. We conclude that, within the error of our measure-
ments, membrane tension is not the driving force behind the
lysis behavior that we see.
Another potential concern with our system is whether the
chamber is well mixed when peptide is injected. We have
three lines of evidence that support our belief that the cham-
ber is well mixed. First, video records clearly show non-
aspirated vesicles flowing quickly by the aspirated vesicles
and pipettes during injection. Second, one can estimate a
characteristic mixing time in the chamber as the length of the
chamber divided by the velocity of the fluid injected into the
chamber. With 100 ,A of fluid being injected through a 0.03
inch hole in 5 s, and a chamber length of 1 inch, one obtains
a value of 0.6 s for the characteristic mixing time. Thus, on
the time scale of lysis, which in the majority of cases occurs
a minute or more after injection, we conclude that the fluid
in the chamber is certainly well mixed. Finally, under the
proper conditions of pH and peptide concentration, we have
observed lysis on the order of a few seconds, such as in the
example given in Fig. 3, which again confirms our belief that
the chamber is well mixed on a time scale of several seconds.
In addition, one might be concerned that the lysis be-
havior we have seen is caused by stochastic failure of the
vesicles resulting from accumulation of lipid on the inside
of our pipettes. Other groups (Needham, 1993; Evans and
Needham, 1987) have added small amounts of BSA to
their experimental buffers to minimize this effect. Al-
though lysis is rapid and occurs in nearly all trials at some
conditions, such as at pH 5, at other conditions, such as
at high pH, a large majority of the vesicles never lyse
within 15 min. These data all serve essentially as negative
controls. Despite the omission of BSA from our buffer,
we feel that the lysis we have reported is caused by pep-
tide X31, and not some nonspecific failure.
Another possible concern about our measurements is that
the stochastic failure of vesicles is caused by multiple bi-
layers. In such a case, one would expect that lysis times
would be arranged in groups or clusters according to the
number of lamellae (Kwok and Evans, 1981). As seen in
Figs. 7 and 8, the lysis times do not suggest a grouping of
lysis times that would be suggestive of multibilayer struc-
tures. As mentioned in Materials and Methods section, our
measured lysis tensions agree within our experimental error
with those of Evans and Needham (1987) for unilamellar
vesicles. Although measurement of the materials properties
of the actual vesicles used in lysis experiments could de-
finitively rule out the possibility of multilamellar vesicles,
we feel we have measured lysis of sufficiently many vesicles
to be confident that our experiments were performed on
unilamellar vesicles.
Our intention in these experiments was to determine if the
X31 peptide could cause fusion of large unilamellar vesicles.
We observed no fusion, even when we manipulated the
vesicles into "contact"; however, "contact" is ill-defined in
our system. Although there is ample evidence that phosphati-
dylcholine membranes will adhere in water free of salt
(Marra and Israelachvili, 1985), we did not observe a large
adhesive region between our vesicles, perhaps because of the
tensions we used to hold the vesicles. Furthermore, the 2%
(0.1 M) glucose solution we used as a buffer should only have
a modest attenuating effect on the van der Waals attraction,
based on calculation made of interbilayer forces in 20% su-
crose (Nir and Bentz, 1978), the fact that we used only 2%
glucose, and that the properties of glucose and sucrose for
van der Waals attraction are similar (Nir and Andersen,
1977). We thus believe egg PC membranes have the potential
to be adherent in 2% glucose buffer. Nevertheless, we do not
have detailed knowledge of the interbilayer separation for
our lipid/solvent system, which can be obtained with x-ray
diffraction (Simon et al., 1994). We do not know if the mem-
branes were too close to exclude peptide, or too far away to
permit fusion. Although our technique holds the potential to
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address the mechanism of membrane fusion, the experiments
here shed little light on whether X31 is capable of mediating
fusion.
In summary, we have combined fluorescence quenching
and video microscopy with micropipette aspiration to de-
velop an assay for membrane lysis. With this assay, new
questions can be answered about the actions of molecules on
biological membranes. For example, there is potential to
measure the materials properties of membranes, such as the
area expansivity modulus, as a function of peptide concen-
tration. Also, the precise relationship between adhesion and
fusion can be assessed, because both can be measured with
micropipette aspiration (Needham, 1993). Because we can
observe single events, we should able to distinguish between
membrane fusion and lysis. Further, by incorporating the
appropriate fluorescent dyes, we should be able to detect
lysis that followed membrane fusion, as is believed to occur
in some systems. We are also able to determine rates of lysis
from the average of single events; we do not have to fit our
data to a model to determine the rates at which lysis or fusion
occurs. We can compare our extent of lysis data, determined
from the number of vesicles that lyse versus the number of
vesicles tested, with previously published results. Our ex-
tents of lysis agree well qualitatively with previously re-
ported values of percent leakage or lysis as induced by pep-
tide X31. Finally, although we did not observe membrane
fusion of egg PC vesicles induced by peptide X31, our assay
has been designed to monitor many types of membrane in-
teraction phenomena, including fusion, and we believe that
it certainly has the potential to do so.
Although we cannot rule out the possibility that peptide
X31 is able to cause fusion at some conditions, our results
and those of other groups suggest that the fusion peptide
alone is not sufficient for membrane fusion to occur. It might
be that a specific lipid and solvent composition is required
to give optimal fusion activity of X31, perhaps by providing
the correct intermembrane separation. It is also possible that
the entire hemagglutinin protein is required to stabilize the
intermediates that occur during fusion. In such a scenario, the
fusion peptide would serve to disrupt one or both apposed
bilayers; the entire protein would form a scaffold on which
the lipids could diffuse. Such models have been proposed by
Stegmann et al. (1990) and Bentz et al. (1990). Although
these models differ in the intermediates formed, both hy-
pothesize that the entire fusion protein is needed to stabilize
the fusion complex; both models are consistent with our
results. We agree with Diizgunes and Shavnin (1992) and
Stegmann et al. (1989), however, that studying the ability of
the fusion peptide to disrupt membranes does have relevance
to fusion induced by the intact hemagglutinin protein, be-
cause the results provide important insights into the role that
the peptide may play in the overall fusion process.
We are currently pursuing experiments in our laboratory
involving fusion molecules reconstituted into model mem-
branes and also virally infected cells to confirm that our assay
is actually able to measure membrane fusion. In addition,
because we were unable to make detailed measurements of
the membrane projections into the pipettes with our current
system, which might allow us to learn more about the mecha-
nism of lysis, we will modify the equipment to include meas-
urement of membrane extension length. Several steps are
involved in lysis, including transport of the peptide to the
vesicle surface, absorption of peptide, and membrane desta-
bilization. Our current measurements do not distinguish be-
tween these steps, but more detailed experiments in which
area dilation is measured might very well elucidate the
mechanism of action of peptides such as X31.
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